MANILA, Philippines — Three developers of vaccines against COVID-19 have passed the review of the ethics board, advancing their applications to conduct clinical trials in the country, the Department of Health (DOH) said Monday.
Belgium’s Janssen Pharmaceutical, United Kingdom’s AstraZeneca, and China’s Clover Biopharmaceuticals have all secured clearance from the Ethical Review Board, said DOH spokesperson Ma. Rosario Vergeire in a forum.
“Approved na rin sa Ethics Review Board ang Janssen, ang AstraZeneca at saka yung Clover. Inaantay na lang po natin lahat na matapos ang mga evaluation nila,” Vergeire said.
(Janssen, AstraZeneca and Clover are all approved by the Ethics Revi…
Keep on reading: Janssen, AstraZeneca, Clover get ethics review board approval — DOH